August 25, 2015
According to GlobalData’s report, the market is set to grow from $29.4 billion in 2014 to $47.9 billion by 2020, which represents a compound annual growth rate of 8.5%.
July 6, 2015

The Harvard Drug Group enhances Cardinal Health's generic distribution business, expands OTC portfolio. 

June 15, 2015

The credibility of the vitamins, minerals and supplements business has been attacked in recent months.

June 5, 2015

Cardinal Health's acquisition of The Harvard Drug Group "further utilizes Red Oak, our joint venture with CVS Health to source generics," CEO says. 

May 19, 2015

Lannett Company buys manufacturer and marketer of liquid generic pharmaceutical products.

May 1, 2015

Amneal Pharmaceuticals and Actavis Australia on Friday announced that Amneal completed the acquisition of most of Actavis’ in-country generic pharmaceuticals business. 

April 20, 2015

Veteran business-development executive Alan Butcher on Monday joined Purdue Pharma. 

April 14, 2015

Taiwan-based drug development company Sunny Pharmtech and Vitruvias Therapeutics, a generic drug development company, on Tuesday announced that they will team up to co-develop a portfolio of generic drug products.

April 13, 2015

Wholesaler distributor H. D. Smith promoted Dmitrey Kuznetsov to SVP, category management.

April 13, 2015

Hi-Tech Pharmaceuticals on Monday acquired Mexican OTC and nutritional manufacturer Advanced Pharmaceuticals and Nutritionals. 

April 8, 2015

Strong same-store sales help lift Rite Aid annual revenue 3.9% to $26.5 billion. 

March 12, 2015

Drug Channels Institute on Thursday listed the leading specialty pharmacy players. 

March 9, 2015

Infirst Healthcare last week picked up the marketing rights to Mylanta and Mylicon from McNeil Consumer. 

February 19, 2015

IRI and Kline & Co. establish an exclusive alliance to provide clients with a greater level of actionable insights.

February 9, 2015

Mylan Inc. and its subsidiary Mylan Pharmaceuticals are being sued by Bayer Healthcare, Bayer Healthcare Pharmaceuticals and Onyx Pharamceuticals in relation to the filing of an abbreviated new drug application for sorafenib tablets, the generic version of Nexavar. 

 

January 12, 2015

Shire and NPS Pharmaceuticals have entered into a merger agreement for a total consideration of $5.2 billion.

 

January 7, 2015

Lupin Pharmaceuticals on Tuesday launched its valsartan tablets USP in 40-, 80-, 160- and 320-mg dosage strengths. The drug is the generic version Novartis's Diovan tablets.

January 7, 2015

The pharmaceutical industry is back. Fueled by the launch of expensive, new biotech medicines, rising prices for both branded and generic drugs and a recent slowdown in branded-drug patent expirations and generic competition, the U.S. pharmaceutical market is staging a remarkable resurgence.

December 17, 2014

The Generic Pharmaceutical Association on Wednesday expressed concerns that the current structure of the Trans-Pacific Partnership agreement (TPP) will impede generic utilization.

December 11, 2014

Are high distribution costs and overly complex regulations stifling pharmaceutical and health product suppliers’ ability to fully engage with the fast-changing healthcare marketplace? That’s one concern raised by a global survey of healthcare executives in the United States, Canada, Europe, Asia and Latin America from United Parcel Service.

December 9, 2014

The University of North Carolina at Chapel Hill received a $100 million donation to the UNC Eshelman School of Pharmacy from alumni Fred Eshelman, founder and CEO of Pharmaceutical Product Development and founding chairman of Furiex Pharmaceuticals. The committment will be used to create a center within the pharmacy school named the Eshelman Institute for Innovation.

December 8, 2014

Acura Pharmaceuticals on Monday announced that the company has been issued its first U.S. patent directed at the company's Impede technology and products utilizing that technology. 

December 4, 2014

Alliance Boots on Thursday announced that it has completed the acquisition of a 12% stake in Nanjing Pharmaceutical in China. As a result of the investment, Alliance Boots becomes the second largest shareholder of the company with the right to nominate board members and a member of the senior management.

November 25, 2014

The Consumer Healthcare Products Association earlier this month added 10 member companies to its roster, including four manufacturer members and six associate members.